SC 13G Filing

Company

Viking Therapeutics, Inc.

Filed

October 10, 2018

Accession Number

0000315066-18-002427

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →